Evelin Tiralongo

Dr. Evelin Tiralongo


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
RRRazina Rouf
Razina Rouf
SUShaikh Jamal Uddin
Shaikh Jamal Uddin
DSDipto Kumer Sarker
Dipto Kumer Sarker
MIMuhammad Torequl Islam
Muhammad Torequl Islam
EAEunus S. Ali
Eunus S. Ali
Satyajit SarkerSatyajit Sarker
Satyajit Sarker

5 April 2006 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
FLF. Lehmann
F. Lehmann
ETEvelin Tiralongo
Evelin Tiralongo
JTJoe Tiralongo
Joe Tiralongo

17 April 2007 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
HCHsiao-Yun Annie Chang
Hsiao-Yun Annie Chang
MWMarianne Wallis
Marianne Wallis
ETEvelin Tiralongo
Evelin Tiralongo

Verified
Journal Article
Open access
PDF file
MHMohamed Ali Abol Hassan
Mohamed Ali Abol Hassan
RRRazina Rouf
Razina Rouf
ETEvelin Tiralongo
Evelin Tiralongo
TMTom May
Tom May
JTJoe Tiralongo
Joe Tiralongo
Lectins are non-immunoglobulin proteins that bind diverse sugar structures with a high degree of selectivity. Lectins play crucial role in various biological processes such as cellular signaling, scavenging of glycoproteins from the circulatory system, cell–cell interactions in the immune system, differentiation and protein targeting to cellular compartments, as well as in host defence mechanisms, inflammation, and cancer. Among all the sources of lectins, plants have been most extensively studied. However, more recently fungal lectins have attracted considerable attention due to their antitumor, antiproliferative and immunomodulatory activities. Given that only 10% of mushroom species are known and have been taxonomically classified, mushrooms represent an enormous unexplored source of potentially useful and novel lectins. In this review we provide an up-to-date summary on the biochemical, molecular and structural properties of mushroom lectins, as well as their versatile applications specifically focusing on mushroom lectin bioactivity.

20 July 2010 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LBLesley A Braun
Lesley A Braun
ETEvelin Tiralongo
Evelin Tiralongo
Jenny WilkinsonJenny Wilkinson
Jenny Wilkinson
OSOndine Spitzer
Ondine Spitzer
MBMichael Bailey
Michael Bailey
MDMichael Dooley
Michael Dooley
Complementary medicines (CMs) are popular amongst Australians and community pharmacy is a major supplier of these products. This study explores pharmacy customer use, attitudes and perceptions of complementary medicines, and their expectations of pharmacists as they relate to these products.

12 January 2011 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SUShaikh J. Uddin
Shaikh J. Uddin
DGDarren Grice
Darren Grice
ETEvelin Tiralongo
Evelin Tiralongo
To investigate the cytotoxic effect of some Bangladeshi medicinal plant extracts, 16 Bangladeshi medicinal plants were successively extracted with n‐hexane, dichloromethane, methanol and water. The methanolic and aqueous extracts were screened for cytotoxic activity against healthy mouse fibroblasts (NIH3T3) and three human cancer‐cell lines (gastric: AGS; colon: HT‐29; and breast: MDA‐MB‐435S) using the MTT assay. Two methanolic extracts (Hygrophila auriculata and Hibiscus tiliaceous) and one aqueous extract (Limnophila indica) showed no toxicity against healthy mouse fibroblasts, but selective cytotoxicity against breast cancer cells (IC50 1.1–1.6 mg mL−1). Seven methanolic extracts from L. indica, Clerodendron inerme, Cynometra ramiflora, Xylocarpus moluccensis, Argemone mexicana, Ammannia baccifera and Acrostichum aureum and four aqueous extracts from Hygrophila auriculata, Bruguiera gymnorrhiza, X. moluccensis and Aegiceras corniculatum showed low toxicity (IC50 > 2.5 mg mL−1) against mouse fibroblasts but selective cytotoxicity (IC50 0.2–2.3 mg mL−1) against different cancer cell lines. The methanolic extract of Blumea lacera showed the highest cytotoxicity (IC50 0.01–0.08 mg mL−1) against all tested cell lines among all extracts tested in this study. For some of the plants their traditional use as anticancer treatments correlates with the cytotoxic results, whereas for others so far unknown cytotoxic activities were identified.